Podrobno

Extracellular cystatin F is internalised by cytotoxic T lymphocytes and decreases their cytotoxicity
ID Prunk, Mateja (Avtor), ID Perišić Nanut, Milica (Avtor), ID Jakoš, Tanja (Avtor), ID Sabotič, Jerica (Avtor), ID Švajger, Urban (Avtor), ID Kos, Janko (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (3,56 MB)
MD5: B5FCEA90FFA7037B47AD076461BC3B0C
URLURL - Izvorni URL, za dostop obiščite https://www.mdpi.com/2072-6694/12/12/3660 Povezava se odpre v novem oknu

Izvleček
Cystatin F is a protein inhibitor of cysteine cathepsins, peptidases involved in the activation of the effector molecules of the perforin/granzyme pathway. Cystatin F was previously shown to regulate natural killer cell cytotoxicity. Here, we show that extracellular cystatin F has a role in regulating the killing efficiency of cytotoxic T lymphocytes (CTLs). Extracellular cystatin F was internalised into TALL-104 cells, a cytotoxic T cell line, and decreased their cathepsin C and H activity. Correspondingly, granzyme A and B activity was also decreased and, most importantly, the killing efficiency of TALL-104 cells as well as primary human CTLs was reduced. The N-terminally truncated form of cystatin F, which can directly inhibit cathepsin C (unlike the full-length form), was more effective than the full-length inhibitor. Furthermore, cystatin F decreased cathepsin L activity, which, however, did not affect perforin processing. Cystatin F derived from K-562 target cells could also decrease the cytotoxicity of TALL-104 cells. These results clearly show that, by inhibiting cysteine cathepsin proteolytic activity, extracellular cystatin F can decrease the cytotoxicity of CTLs and thus compromise their function.

Jezik:Angleški jezik
Ključne besede:cystatin F, cathepsins, cytotoxic lymphocytes, granzymes, perforin, TALL-104
Vrsta gradiva:Članek v reviji
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:FFA - Fakulteta za farmacijo
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2020
Št. strani:14 str.
Številčenje:Vol. 12, iss. 12, art. 3660
PID:20.500.12556/RUL-134854 Povezava se odpre v novem oknu
UDK:616.1
ISSN pri članku:2072-6694
DOI:10.3390/cancers12123660 Povezava se odpre v novem oknu
COBISS.SI-ID:43955203 Povezava se odpre v novem oknu
Datum objave v RUL:04.02.2022
Število ogledov:1994
Število prenosov:275
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Cancers
Skrajšan naslov:Cancers
Založnik:MDPI
ISSN:2072-6694
COBISS.SI-ID:517914137 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.
Začetek licenciranja:06.12.2020

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:cistatin F, katepsini, citotoksični limfociti

Projekti

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:J4-1776
Naslov:Izboljšanje imunoterapevtske vrednosti NK celic z modulacijo cistatina F

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:P4-0127
Naslov:Farmacevtska biotehnologija: znanost za zdravje

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj